ISDA

Entry Detail

PDB ID:

2C6T

Keywords:

CELL CYCLE

Title:

Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor

Biological Source:

Source Organism:

HOMO SAPIENS

Host Organism:

ESCHERICHIA COLI

PDB Version:

Deposition Date:

2005-11-11

Release Date:

2005-12-07

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.61 Å

R-Value Free:

0.25

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:CELL DIVISION PROTEIN KINASE 2
Chain IDs:A, C
Chain Length:298
Number of Molecules:2
Biological Source:HOMO SAPIENS

UniProt ID:P24941 Pfam ID:PF00069

Protein Blast

Polymer Type:polypeptide(L)
Description:CYCLIN A2
Chain IDs:B, D
Chain Length:258
Number of Molecules:2
Biological Source:HOMO SAPIENS

UniProt ID:P20248 Pfam ID:PF00134, PF02984

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
TPO	A	THR	PHOSPHOTHREONINE

Ligand Molecules

DT5

Primary Citation

Triazolo[1,5-A]Pyrimidines as Novel Cdk2 Inhibitors: Protein Structure-Guided Design and Sar.

Richardson, C.M, Williamson, D.S, Parratt, M.J, Borgognoni, J, Cansfield, A.D, Dokurno, P, Francis, G.L, Howes, R, Moore, J.D, Murray, J.B, Robertson, A, Surgenor, A.E, Torrance, C.J.Show

Bioorg.Med.Chem.Lett. 16 1353 ? (2006)

PMID: 16325401 DOI: 10.1016/J.BMCL.2005.11.048

Abstact

Crystallographic and modelling data, in conjunction with a medicinal chemistry template-hopping approach, led to the identification of a series of novel and potent inhibitors of human cyclin-dependent kinase 2 (CDK2), with selectivity over glycogen synthase kinase-3beta (GSK-3beta). One example had a CDK2 IC(50) of 120 nM and showed selectivity over GSK-3beta of 167-fold.

Legend

Protein

Chemical

Disease

Primary Citation of related structures